Learning Objectives
Upon completion of this activity, participants should be able to:
- Identify the current indications for recently approved novel antiretroviral agents
- Discuss key factors to be considered in managing a treatment-experienced patient who is experiencing persistent low-level viremia
- Discuss the reasons for including at least 2 new fully active agents when switching a patient to a new antiretroviral regimen
Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.